Quick answer — COMMERCIAL MEDICINES UNITLast refreshed 16 Jun 2017

At a glance

COMMERCIAL MEDICINES UNIT has awarded £2.3bn across 17 suppliers, with 1 live contract.

Why: Top supplier share 2% · 1 open notice now · 0 awards in last 90 d (£0) · SME share 0% (Cabinet Office target 33%) · 0 modifications in last 90 d.

Decision signals
Top-supplier concentration2%
Modifications · 90 d0
SME spend share0%
Pipeline · open now1
Awards · 90 d0

About this buyer

Mission, scope and statutory context.

COMMERCIAL MEDICINES UNIT is a contracting authority, based in United Kingdom. Tracks 42 published notices and 42 awards on PublicSupply.

42
Notices published
42
Awards
17
Suppliers engaged
2015
First award on file

Spend profile

Award value by month — rolling 24 months. Line shows 12-month moving average.

£0
12 m spend
£0
Prior 12 m
YoY change
£40.0m
Median award
Awards (£m)12m moving avg
COMMERCIAL MEDICINES UNIT — monthly award value, rolling 24 months£0m£0m£1m£1m£1mJulOctJanAprJulOctJanApr

Contract pipeline

Forward flow — planned notices through to completed awards in the last 90 days.

Planned

0

Pipeline notices

Open (bidding)

1

Live tenders

Awarded (90d)

0

£0

Frameworks open

0

Framework / DPS routes

Procurement mix

How this buyer procures — by procedure, instrument, and publication source.

Contract type

Unspecified42 · £2.3bn

Instrument type

contract37 · £1.4bn
call off5 · £940.8m
Source:Contracts Finder: 42

Awarded contracts · 1 live

All contracts with a published award notice where COMMERCIAL MEDICINES UNIT is the contracting authority.

downloadExport CSV
TitleSupplierCPVValueAwardedStatus
Strategic stockpile of medicines 2017Actavis UK Ltd33600000£018 Apr 2017active
Strategic stockpile of medicines 2017Wockhardt UK Ltd33600000£018 Apr 2017active
Strategic stockpile of medicines 2017Bowmed Ibisqus Ltd33600000£018 Apr 2017active
Strategic stockpile of medicines 2017Bayer Plc33600000£018 Apr 2017active
Strategic stockpile of medicines 2017Accord Healthcare Ltd33600000£018 Apr 2017active
Strategic stockpile of medicines 2017Sigma Pharmaceuticals Plc33600000£018 Apr 2017active
Strategic stockpile of medicines 2017Kent Pharmaceuticals Ltd33600000£018 Apr 2017active
Dynamic Purchasing System (DPS) for the supply of antibiotics and IV fluids33690000£0active
Invitation to offer for NHS National Framework Agreement for the supply of Human Albumin and Human Anti-D Immunoglobulin33141540£21.1m04 Apr 2017active
NHS National Framework Agreement for the supply of Nitric Oxide Therapy. To include the supply of gas, rental of cylinders and delivery equipment, maintenance and consumablespost24111000£15.0m17 Mar 2016active
Showing 110 of 57

Top suppliers · by total award value

Ranked by cumulative awarded value. YoY = last 12 months vs prior 12 months.

1
PO
2 contracts · 17 Mar21 Nov
£53.0m
2% of total
2
AU
1 contract · 18 Apr
£0
0% of total
3
WU
1 contract · 18 Apr
£0
0% of total
4
BI
1 contract · 18 Apr
£0
0% of total
5
BP
1 contract · 18 Apr
£0
0% of total
6
AH
1 contract · 18 Apr
£0
0% of total
7
SP
1 contract · 18 Apr
£0
0% of total
8
KP
2 contracts · 12 Jan18 Apr
£0
0% of total
917
···
9 other suppliers
long tail · 0 SMEs
£0
0% of total
various

Category spend breakdown

By CPV division · lifetime awards

Medical, pharmaceutical
55 contracts
£2.3bn
98%
Health & social work
1 contract
£38.0m
2%
Chemicals
1 contract
£15.0m
1%

Activity heatmap

Award volume by CPV division × month. Darker = more £ awarded.

Jul
Aug
Sept
Oct
Nov
Dec
Jan
Feb
Mar
Apr
May
Jun
Medical, pharmaceutical
Health & social work
Chemicals
LessMore (£m awarded)

Commercial & procurement leadership

Who signs off contracts, owns frameworks and runs SME engagement.

Coming Q3 2026

Curated leadership roster

Chief commercial officer, framework owners, SME lead and clinical sign-offs per buyer. Top-50 contracting authorities first, rolling out by sector.

Modifications · 0 in 90 d

Variations logged under Procurement Act 2023 s.74. Above-tolerance modifications attract a flag.

Total mods
0
Above tolerance
0
Total value
£0
Novations
0

No modifications recorded in the last 90 days.

COMMERCIAL MEDICINES UNIT has not filed a modification notice in the selected window.

Compliance & transparency

FOIA performance, statutory disclosures & prompt payment.

Coming Q4 2026

FOIA & prompt-payment ingestion

Notice timeliness and modification flags are derivable today. FOIA refusal rate, prompt-payment %, KPI reporting and net-zero plans need new data sources — work scoped, ingestion next quarter.

SME & social value

Performance against Cabinet Office targets & PPN 06/20.

0%
SME supplier share
target 33%
0
SME award rows
0
VCSE award rows
17
Distinct suppliers
⚠ Below target. SME supplier share at 0% vs Cabinet Office target of 33%.

Peer benchmark

vs other buyers in the same type. Highlighted row = this buyer.

Upgrade to Pro

Compare against the peer group

£149 / seat / month. Configurable peer groups, rolling trendlines, and CSV / PDF exports for board packs.

News mentions

Major UK press & trade publications.

Free with account

Sign in to read news mentions

Article previews are free with an account — the underlying data is gated to satisfy publisher agreements.

Statutory & accountability

Legal status, identifiers & accountable officers.

Identifiers & contact

Type
Contracting authority
Region
United Kingdom

Board & accountable officers

Coming Q3 2026

Accountable officer + board roster

Pulled from gov.uk for arm's-length bodies and from Companies House for company-form buyers — chair, CEO, SRO and sign-off authority per contract band.

Resources

No verified links for COMMERCIAL MEDICINES UNIT yet. Know one? Suggest it below.

Share this profile

Citation for journalists & researchers available via API.